Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04595201 · ClinicalTrials.gov registry record

Clinical Follow-up of Pregnant Subjects Undergoing NIPT

A clinical trial of Pregnancy, sponsored by Sequenom.

Recruiting
Registry status
25,000
Enrollment target
1
Study location

NCT04595201: Recruiting study of Pregnancy, sponsored by Sequenom.

NCT04595201 is a study of Pregnancy that is actively recruiting participants, run by Sequenom. The registered enrollment target is 25,000 participants, above the 742-participant average among 191 other Pregnancy trials with a reported enrollment target (3269% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04595201, a study of Pregnancy, is actively recruiting participants, sponsored by Sequenom.

RECRUITING
Registry status
25,000 participants
Enrollment target
1
Study location

Study Summary

To obtain pregnancy outcome data from patients screened for fetal genetic status using non-invasive pregnancy testing (NIPT).

Primary Outcome

Sensitivity

Conditions Studied

Interventions

  • DEVICE NIPT

Study Locations (1)

Massachusetts

  • Integrated Genetics - Westborough

Trial Details

FieldValue
Enrollment Target 25,000 participants
Start Date 2020-10-13
Est. Completion 2025-10-13
Sequenom

26 total trials

What NCT04595201 shows while recruiting

NCT04595201 is an observational study that tracks outcomes without assigning an intervention. Its 25,000 participants enrollment target places it among the larger protocols in the corpus, above the 742-participant average among 191 other Pregnancy trials with a reported enrollment target (3269% higher).

The record links to 1 condition, with Pregnancy appearing as the primary indexed condition, and to 1 intervention - of which NIPT is the first listed.

NCT04595201 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT04595201 about?

NCT04595201 is a clinical study titled "Clinical Follow-up of Pregnant Subjects Undergoing NIPT". To obtain pregnancy outcome data from patients screened for fetal genetic status using non-invasive pregnancy testing (NIPT).

What is the current status of trial NCT04595201?

This trial is currently recruiting. The enrollment target is 25,000 participants. The study started on 2020-10-13. Estimated completion is 2025-10-13.

What conditions does trial NCT04595201 study?

This clinical trial studies the following conditions: Pregnancy.

What interventions are being tested in trial NCT04595201?

The interventions under investigation include: NIPT (DEVICE).

Who is sponsoring clinical trial NCT04595201?

This trial is sponsored by Sequenom, which has 26 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04595201 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pregnancy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04595201's enrollment target sits among peer trials

25,000 2nd of 191 the highest of 191 other Pregnancy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Pregnancy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04994015 · 25,000 participants

    Parkinson's Foundation PD GENEration Genetic Registry

  • NCT06589310 · 25,000 participants

    Falcon Real World Evidence Registry

  • NCT06773897 · 25,000 participants

    Rutgers University Study of the Genetics of Breast Cancer.

  • NCT06774417 · 25,000 participants · NA

    Digital Strategies to Advance Help-Seeking - Aim 3

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04595201, the US trial registry maintained by the National Library of Medicine. NCT04595201 (large enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.